NPAS2 and hepatocellular carcinoma: A later study of Yuan et al. has demonstrated a significant association between rs2305160 in NPAS2 and overall death risk in hepatocellular carcinoma patients under genetic dominant model (HR = 1.63 (1.29–2.07), p < 0.001) [25].